Decompensated Cirrhosis
📧 Sign up to get email alerts when something new happens for Decompensated Cirrhosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: HCL001 Cell Injection for Decompensated Cirrhosis: A Phase I/II Trial [Phase 1, Phase 2]
This is an update on a Phase 1/2 cell therapy trial (HCL001) for decompensated cirrhosis, with enrollment ongoing by invitation.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: New Prognostic Predictive Models of Mortality of Decompensated Cirrhotic Patients Waiting for Liver Transplantation [NA]
This study completed development of predictive models to estimate mortality risk for patients with decompensated cirrhosis awaiting liver tr…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Using Telemedicine to Assist in the Clinical Care of Patients With Decompensated Cirrhosis [NA]
A trial update describing a telemedicine study to assist care for patients with decompensated cirrhosis; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis [Phase 2]
Phase 2 clinical trial evaluating the use of statins and beta blockers in patients with decompensated cirrhosis; currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites [Phase 3]
Phase 3 trial evaluating personalized long-term human albumin treatment for patients with decompensated cirrhosis and ascites is currently r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: RTX001 Autologous Engineered Macrophages for Liver Cirrhosis [Phase 1, Phase 2]
RTX001 is an autologous engineered macrophage therapy being investigated in Phase 1/2 trials for end-stage liver disease and liver cirrhosis…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy [Phase 2]
Genfit's Phase 2 trial of the investigational medicine VS-01 for hepatic encephalopathy in patients with acute-on-chronic liver failure and …
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Effect of Whey Protein Versus Egg Albumen Protein Challenge on Blood Ammonia Level in Patients of Decompensated Ethanol Related Cirrhosis. [NA]
A clinical trial comparing whey protein versus egg albumen protein to assess effects on blood ammonia in patients with decompensated ethanol…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Study to Evaluate the Efficacy of Intravenous Administration of Human Albumin Versus Saline Solution in Patients With descompénsate Cirrhosis Grade 1B or Higher Renal Failure [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy of intravenous human albumin versus saline solution in patients with decompensated cirrh…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Concordance Between Echocardiographic Assessment Performed in the Initial Phase of Decompensated Cirrhosis With Edema and Ascites by an Expert Intensive Care Physician and a Non-expert Gastroenterologist
This clinical trial update evaluates concordance between echocardiographic assessments performed by an expert intensive care physician and a…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD) [NA]
A clinical trial evaluating the integration of palliative care into the treatment of end-stage liver disease has completed, with results pos…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic Patients [Phase 3]
Phase 3 clinical trial evaluating oral branched-chain amino acid supplementation in patients with decompensated cirrhosis and ascites; curre…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Single vs Repeated Cycle of Granulocyte Colony-Stimulating Factor (GCSF) & Darbepoetin in Early Decompensated Cirrhosis [NA]
A clinical trial from the Institute of Liver and Biliary Sciences comparing a single versus repeated cycle of granulocyte colony-stimulating…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Hospital @ Home Model of Care for Cirrhosis [NA]
This clinical trial, sponsored by Indiana University, is evaluating a Hospital-at-Home model of care for patients with decompensated cirrhos…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
A recruiting clinical trial evaluating new prognostic biomarkers in patients with liver cirrhosis, focusing on the decompensated stage.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
This clinical trial aims to predict recompensation in patients with decompensated cirrhosis using spleen stiffness measurements and simple b…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE [Phase 4]
Phase 4 clinical trial comparing branched-chain amino acids to rifaximin for secondary prophylaxis of hepatic encephalopathy in patients wit…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival [NA]
This clinical trial evaluates whether adding simvastatin to carvedilol improves hepatic decompensation and survival in patients with decompe…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites [Phase 3]
Phase 3 trial evaluating long-term administration of human albumin in people with decompensated cirrhosis and ascites has completed and resu…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D). [NA]
CoPA-D is a completed clinical trial evaluating the effect of albumin on coagulation parameters in patients with Decompensated cirrhosis.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: CirrhoCare- Using Smart-phone Technology to Enhance Care and Access to Treatment for Cirrhosis [NA]
Ongoing clinical trial CirrhoCare uses smartphone technology to enhance care and access to treatment for decompensated cirrhosis; the study …
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Effect of Non-Selective Beta-Blockers on Outcomes in Cirrhosis Patients After Hospitalization: A Retrospective Cohort Using Target Trial Design
This retrospective cohort study uses a target trial design to evaluate whether non-selective beta-blockers influence outcomes in cirrhosis p…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: LEOPARD Training and Validation Data Collection Study
LEOPARD is a training and validation data collection study that is currently recruiting to assemble data for liver disease conditions includ…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Low-dose Albumin Infusion for the Prevention of Paracentesis Induced Circulatory Dysfunction (PICD), After Large Volume Paracentesis (LVP) in Decompensated Cirrhosis Liver. [Phase 4]
Phase 4 clinical trial conducted in Bangladesh completed evaluating low-dose albumin infusion to prevent paracentesis-induced circulatory dy…
-
CLINICAL_TRIALS research · 2025-03-19Clinical Trial Update: A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial). [Phase 2]
Phase 2 clinical trial evaluating a combinatorial therapy using albumin and enoxaparin in patients with decompensated cirrhosis at high risk…